Insurance denials and out-of-pocket costs may prevent many people with blood cancer from receiving oral medications, and the FDA approves a treatment for locally advanced rectal cancer.
At the recent AACR Conference on Pancreatic Cancer, researchers explored the complex interactions among tumor cells, neurons, and the tumor microenvironment, and what these discoveries could mean for future therapeutic strategies.
Studies reveal varying associations between ethnic enclaves and cancer outcomes, but researchers aim to identify community strengths that could improve care.
Families who travel far for treatment may face financial toxicity and insurance hurdles.
Breast cancer mortality rates have declined overall, but women who live in rural areas have not experienced the same progress as those in more populated areas.
Updated results from a survey first published in the AACR Cancer Disparities Report 2026 reveal the impact of federal policy changes on cancer disparities researchers. Additional highlights from the report were also shared during...
At the AACR Conference on The Science of Cancer Health Disparities, Justin Xavier Moore, PhD, MPH, of the University of Kentucky, shared a study on how neighborhood disadvantage impacts mortality rates for early-onset colorectal...
Like millions of people, Pope Leo XIV was diagnosed with lung cancer. This disease, though still serious, has also been transformed from one of daunting odds to a surmountable affliction thanks to decades of...
At the recent AACR Conference on Pancreatic Cancer, Kevan M. Shokat, PhD, FAACR, received the 2026 Stephenson Global Prize for his pioneering discoveries that opened the door to the development of RAS-targeted therapies. Read...
The Friends of the AACR Foundation will honor Domenick Bucci, MD, as the Humanitarian Honoree and the HEADstrong Foundation as the Community Impact Award recipient at this year’s Party with a Purpose. Learn more...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More